CT:IQ is thrilled to announce our newest Steering Committee member, ObvioHealth.
ObvioHealth, a virtual research organisation (VRO), brings a wealth of experience and expertise in conducting decentralised clinical trials (DCTs) that produce stronger therapeutic evidence. Its mission is to conduct innovative and efficient trials using technology to capture more robust and accurate data—so life-improving innovations can get to market faster.
ObvioHealth has been innovating clinical trials since 2017, when it launched one of the first-ever DCT platforms with a mobile app. Today, ObvioHealth is an industry leader, designing and running DCTs across the globe.
We are pleased to welcome ObvioHealth to CT:IQ and look forward to working together on upcoming clinical trials projects.
